Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

Biopharma: The Elements of Training

October 4, 2013

Establishing a well-defined training program is a crucial activity for any biopharmaceutical organization, writes Susan J. Schniepp.

Market Access is Dead

October 1, 2013

Patient access is the new driver of change and progress in healthcare marketing, says a senior industry player in market development.

Not Much Ado About the ACA

October 1, 2013

With key provisions of the Affordable Care Act set to launch this month, industry veteran Mason Tenaglia says the impact all depends on what you sell and where you sit.

12th Annual Pharmaceutical Industry Audit

October 1, 2013

With revenues down and margins squeezed by a realigning payer pool, the power to price above the market is the ticket to the top—no discounts allowed.

Field Force Evolution: Adapting to a New Ecosystem

October 1, 2013

Environmental changes on all sides of professional sale are forcing biopharmaceutical companies to select for new traits in the makeup of the field force function.

Taking Stock: Notes on the Industry Audit

October 1, 2013

Our October issue highlights a latent threat to Big Pharma: the behavioral mindset that may be best characterized as "ageing in place."

Making Sense of the Sunshine Act

September 1, 2013

The Sunshine Act's Open Payments spending disclosure program is now live. The government's lead compliance officer explains how it will work.

Share of Screen: Prioritizing Electronic Health Records

September 1, 2013

Are electronic health records a viable channel for engagement? Ben Comer reports.

Crunch TIme for Emerging Markets

September 1, 2013

Normal service will be resumed as soon as possible.

ADVERTISEMENT

Click here